Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

DRE Health Plans Face Mask Manufacturing Plant in United States

03/05/2020
DRE Health Corporation, a Kansas City, Missouri-based manufacturer, wholesaler, distributor, and retailer of medical equipment, instruments, and supplies plans to build a manufacturing plant for disposable face masks in the United States in response to the recent global Coronavirus outbreak, along with a disposable glove production plant.

According to company officials, as of March 2nd there are over 100,000 confirmed cases of COVID-19 (Coronavirus) worldwide, a virus that has gained global media attention and may cause a national pandemic. The Coronavirus has claimed over 3,200 lives internationally and 9 in the United States, exceeding the worldwide deaths from the SARS virus. The CDC warned that "this may be bad". As panic grows quickly, a worldwide shortage of face masks has been established, and DRE Health, a global manufacturer of healthcare consumable products including face masks, aims to help solve the problem at home here in the States.’

"We have received worldwide purchase inquiries from customers exceeding 250,000,000 masks, there is a serious global supply chain issue," said DRE CEO Isaac Bawany. "The cost of the raw filtration material has gone up over 50-fold since this January due to the Coronavirus outbreak. Our customers here in the US are completely wiped out of inventory.”

"We will have our plant up and running the second week of March, we expect to be able to produce several million pieces per day. We are intending on selling these masks with priority given to US customers to protect the security of the Homeland."

He added, "We are really big on supporting the US economy, we are currently in a planning phase for opening a disposable glove manufacturing facility in the US as well, a project expected to add several hundred jobs and to cost upward of $40 million."

Exclusive Research